Back to Search
Start Over
Initiates Feasibility Studies on DNA Delivery with Chiron and Bayer Corp
- Source :
- BioAccess. April 1999, Vol. 7 Issue 4
- Publication Year :
- 1999
-
Abstract
- Toulouse, France, March 16, 1999 - Biovector Therapeutics SA, a privately held company, specialising in delivery systems for biotechnology products, reports a signed feasibility agreements with both Chiron and Bayer [...]
Details
- Language :
- English
- ISSN :
- 13563432
- Volume :
- 7
- Issue :
- 4
- Database :
- Gale General OneFile
- Journal :
- BioAccess
- Publication Type :
- News
- Accession number :
- edsgcl.54276000